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Abstract
Background: MicroRNA (miRNA) sponges with multiple tandem miRNA binding sequences can sequester miRNAs from
their endogenous target mRNAs. Therefore, miRNA sponge acting as a decoy is extremely important for long-term loss-
of-function studies both in vivo and in silico. Recently, a growing number of in silico methods have been used as an
effective technique to generate hypotheses for in vivo methods for studying the biological functions and regulatory
mechanisms of miRNA sponges. However, most existing in silico methods only focus on studying miRNA sponge
interactions or networks in cancer, the module-level properties of miRNA sponges in cancer is still largely unknown.
Results: We propose a novel in silico method, called miRSM (miRNA Sponge Module) to infer miRNA sponge modules in
breast cancer. We apply miRSM to the breast invasive carcinoma (BRCA) dataset provided by The Cancer Genome Altas
(TCGA), and make functional validation of the computational results. We discover that most miRNA sponge interactions
are module-conserved across two modules, and a minority of miRNA sponge interactions are module-specific, existing
only in a single module. Through functional annotation and differential expression analysis, we also find that the modules
discovered using miRSM are functional miRNA sponge modules associated with BRCA. Moreover, the module-specific
miRNA sponge interactions among miRNA sponge modules may be involved in the progression and development of
BRCA. Our experimental results show that miRSM is comparable to the benchmark methods in recovering experimentally
confirmed miRNA sponge interactions, and miRSM outperforms the benchmark methods in identifying interactions that
are related to breast cancer.
Conclusions: Altogether, the functional validation results demonstrate that miRSM is a promising method to identify
miRNA sponge modules and interactions, and may provide new insights for understanding the roles of miRNA sponges
in cancer progression and development.
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Background
MicroRNAs (miRNAs) are small (~22 nt), single-
stranded, non-coding RNA molecules which are involved
in the post-transcriptional regulation of gene expression.
By binding to target mRNAs, miRNAs typically cause
degradation and translation repression of mRNAs [1].
The fine-tuning of gene regulation by miRNAs in a
wide range of biological processes and tumor pro-
gressions has attracted significant attentions to
understand the biological functions and regulatory
mechanisms of miRNAs.
Recently, the competing endogenous effect at the post-
transcriptional level has shifted our understanding of
miRNA regulatory mechanism. There are several types of
RNAs acting as competing endogenous RNAs (ceRNAs)
(also called miRNA sponges or miRNA decoys) to prevent
miRNAs from binding their authentic targets. These
miRNA sponges include protein-coding RNAs, long non-
coding RNAs (lncRNAs), pseudogenes and circular RNAs
(circRNAs) [2–5]. More and more miRNA sponges in
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different biological conditions have been identified by bio-
logical experiments [6]. These miRNA sponges interact
with each other via shared miRNAs, and the crosstalks
between them are formed to develop miRNA-mediated
interaction or miRNA sponge interaction network. How-
ever, similar to miRNA target prediction, the identification
of miRNA sponge interaction networks by using biological
experiments is limited by their low efficiency, time
consumption and high cost. Thus, a growing number of
computational methods have been proposed to identify
miRNA sponge interaction networks.
Existing computational methods for identifying miRNA
sponge interaction networks can be divided into three cat-
egories [7]: (1) pair-wise correlation approach, (2) partial
association approach, and (3) mathematical modelling ap-
proach. In the first category [8–11], each pair of interact-
ing miRNA sponges in a network have a significant
positive correlation or there is a significant difference in
their correlation between two different conditions. The
main limitation of these methods is that they don’t con-
sider the expression levels of the miRNAs shared by the
two miRNA sponges when computing the correlation be-
tween the miRNA sponge pair. To address this limitation,
methods of the second category [12–14] integrate the
expression levels of the shared miRNAs of two
miRNA sponges and calculate the partial association
between them. These methods only use unweighted
bipartite network consisting of putative miRNA-target
interactions, but ignore the binding strengths between
miRNAs and their targets. Moreover, some identified
miRNA sponge interactions in the network are actu-
ally TF-target interactions or protein-protein interac-
tions (PPIs), and should be removed. The third
category [15–18] focuses on decribing a minimum or
small miRNA sponge interaction network using differ-
ent mathematical models. For each candidate miRNA
sponge interaction, they would design a synthetic
gene circuit to analyze the quantitative behavior of
the miRNA sponge effect. The number of candidate
miRNA sponge interactions is usually large. Since it
is very time-consuming of designing many synthetic
gene circuits for a large number of miRNA sponge
interactions, these methods cannot be easily applied
to study a larger miRNA sponge interaction network.
The identification of miRNA sponge interaction net-
works could provide a global view of studying the prop-
erties of miRNA sponges in cancer progression and
development. Due to the modularity of cancer progres-
sion and development, it is also important to identify
functional modules that involve miRNAs and miRNA
sponges. Therefore, in this study, we present a novel
computational method based on biclustering and regula-
tory scores to identify miRNA Sponge Modules (thus
the proposed method is called miRSM).
We explore mRNA-related miRNA sponge modules by
combining matched miRNA and mRNA expression data,
and putative miRNA-target interactions. Instead of com-
pletely relying on putative miRNA-target interactions, we
reconstruct miRNA-target interactions by considering
both expression data and miRNA-target binding informa-
tion. We use regulatory scores to infer miRNA-mRNA
biclusters where a subset of mRNAs compete with each
other to attract binding with a subset of miRNAs. We
further identify miRNA sponge interactions in each
miRNA-mRNA bicluster, and remove the candidate
miRNA sponges which are not involved in any miRNA
sponge interactions. The remaining candidate miRNA
sponges and miRNAs in each bicluster are regarded as a
miRNA sponge module.
The method is applied to the breast invasive carcinoma
(BRCA) dataset provided by The Cancer Genome Altas
(TCGA) to build miRNA sponge modules in BRCA. We
discover that a few number of miRNA sponge interactions
only exist in single module, and most miRNA sponge in-
teractions are common across two modules. This result
shows the module-conserved characteristic of miRNA
sponge interactions across two different modules. More-
over, miRNA sponges of the modules are found to be
biologically meaningful based on functional annotation
and differential expression analysis. Through experimental
validation using the thrid-party databases, some miRNA
sponge interactions and miRNA-target interactions
are experimentally validated. Finally, the comparison
results show that miRSM performs better than or
comparable to the other three existing methods (PC




The matched miRNA and mRNA expression data of
human BRCA are obtained from Paci et al. [12]. The
dataset is generated with the platform of TCGA level 3
IlluminaHiSeq in 72 matched tumor and normal tissues.
miRNAs and mRNAs with missing values in >50% sam-
ples are removed from the dataset. The remaining miss-
ing values are imputed using the k-nearest neighbours
(KNN) algorithm of the R package impute. Furthermore,
we remove the mRNAs without gene symbols and take
the average expression values of replicate miRNAs and
mRNAs. Therefore, we obtain 453 miRNAs and 11,157
mRNAs in the 72 matched samples.
The putative miRNA-target interactions are from
TargetScan v7.1 [19]. We retain those miRNA-target
interactions with context++ scores less than 0 in
TargetScan. The context++ score for each miRNA-target
interaction is the sum of the contributions of 14 robustly
selected features [19]. As a result, we obtain 228,423
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interactions (with negative context++ scores) between 402
mature miRNAs and 12,441 mRNAs. In this study, we
choose two representative databases of experimentally vali-
dated human TF-target interactions and PPIs to illustrate
the method. The first database HTRIdb [20] is a popular
repository of experimentally verified human transcriptional
regulation interactions, and we collect 51,871 TF-target in-
teractions from it. The second database HPRD v9 (Human
Protein Reference Database) [21] is a well-cited human
protein reference database with high-quality PPIs, and we
obtain 36,852 protein-protein interactions (PPIs) from it.
A list of 40 Gene Ontology (GO) terms associated with
10 cancer hallmarks is from Plaisier et al. [22], and the
gene sets of these hallmark-associated GO terms are
obtained from MsigDB v5.1 [23]. The list of 2949 breast
cancer genes are collected from COSMIC v77 [24], GAD
[25], OMIM [26], BCGD [27] and G2SBC [28]. The list of
428 breast cancer miRNAs are obtained by integrating five
databases: HMDD v2.0 [29], miR2Disease [30], miRCancer
[31], oncomiRDB [32] and phenomiR v2.0 [33].
The experimentally validated miRNA-target interactions
with strong evidence are from miRTarbase v6.1 [34]. The
experimentally validated miRNA sponge interactions are
retrived from [6, 7], and miRSponge [35], the first manu-
ally curated miRNA sponge interactions database. We only
extract experimentally validated mRNA-related miRNA
sponge interactions for validations.
Overview of miRSM
Figure 1 depicts the pipeline of miRSM. The overall
process of miRSM for identifying miRNA sponge modules
includes the following steps:
(1) Data preparation. We firstly collect expression profiles
and miRNA-target binding information. The expression
profiles of miRNAs and mRNAs, and the context++
scores of miRNA-target interactions are regarded as
input dataset of the next step.
(2) Create miRNA-mRNA regulatory score matrix. We
firstly use Pearson correlation method to calculate
miRNA-mRNA correlation matrix,W, of the matched
miRNA and mRNA expression data. Based on the
putative miRNA-target binding information retrieved
from TargetScan, we generate the miRNA-mRNA
context++ score matrix, T. By combining the
correlation matrix and the context++ score matrix, we
create miRNA-mRNA regulatory score matrix, S.
(3) Infer miRNA-mRNA biclusters. The miRNA-
mRNA regulatory score matrix is regarded as the
input matrix of the biclustering method. A subset of
mRNAs exhibit similar behavior across a subset of
miRNAs in each bicluster.
(4) Identify miRNA sponge modules. Pearson correlation
method is used to compute the correlations of all
possible mRNA-mRNA pairs of each bicluster. We use
the regulatory scores between miRNAs and mRNAs to
reconstruct miRNA-target interactions, and a
hypergeometric test is utilized to evaluate the
significance of the sharing of miRNAs by each mRNA-
mRNA pair. The mRNA-mRNA pairs with significant
sharing of miRNAs (p-value <0.01) and significant
positive correlation (p-value <0.01) are regarded as
candidate miRNA sponges and their interactions as
candidate miRNA sponge interactions. Moreover, we
remove the candidate miRNA sponge interactions that
are actually TF-target interactions or PPIs and the
candidate miRNA sponges which are not involved in
any miRNA sponge interactions are removed too.
Finally, the remaining candidate miRNA sponges and
miRNAs in each
bicluster are considered as a miRNA sponge module.
In the following, we will present the key steps in detail.
Calculating miRNA-mRNA regulatory scores
The regulatory scores denote the degree of regulation
between miRNAs and mRNAs considering both their
correlations and context++ scores. The correlations be-
tween miRNAs and mRNAs are based on the matched
miRNA and mRNA expression data, and the context++
scores of miRNA-mRNA interactions are extracted from
TargetScan v7.1 [19]. Let W be miRNA-mRNA correl-
ation matrix, and T be miRNA-mRNA context++ score
matrix. The miRNA-mRNA regulatory score matrix S is
calculated as follows:
S ¼ a W þ b  T ð1Þ
where a and b are tuning parameters with the value
range of [0, 1], and the default values of them are set to
0.5, indicating that expression data and putative
miRNA-target binding information contribute equally to
the regulatory scores of miRNA-mRNA interactions.
Since the value ranges of the elements of W and T are
[−1, 1] and [−1, 0] respectively, when a and b take their
default value (0.5), the (default) value range of the
elements of S is [−1, 0.5].
In this study, we use the regulatory scores of miRNA-
mRNA interactions to reconstruct putative miRNA-target
interactions. We only consider negative values of the regu-
latory scores in S due to negative regulation of miRNAs.
According to the empirical experiments, the negative
correlation of two variables is around −0.3 under sig-
nificant level of p-value <0.05. Thus, the default
threshold s of regulatory scores is set to −0.3. That is
to say, the miRNA-target interactions with regulatory
scores equal to or less than s are regarded as recon-
structed miRNA-target interactions.
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Fig. 1 (See legend on next page.)
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Identifying miRNA sponge modules
Given the miRNA-mRNA regulatory score matrix with
m rows in n columns, the biclustering method allows
simultaneous clustering the rows (mRNAs) and columns
(miRNAs) of the matrix. Here, a bicluster corresponds a
module. For each bicluster, a subset of mRNAs exhibit
similar behavior across a subset of miRNAs. To identify
miRNA-mRNA biclusters, a biclustering method called
BCPlaid [36] is used. The BCPlaid is an improved ver-
sion of Plaid model [37]. The Plaid model estimates the
normal expression level of each gene, then infers biclus-
ters of genes that have similarly unusual expression
levels across the biclustered samples. This feature makes
it an attractive method for clustering expression data.
To improve the computationally efficient for fitting the
Plaid model, the BCPlaid is presented based on speedy
individual differences clustering and uses binary least
squares to update the cluster membership parameters.
After obtaining the biclusters, we calculate correla-
tions of all mRNA-mRNA pairs of each bicluster. For a
given mRNA-mRNA pair (mR1 and mR2), the signifi-
cance p-value of the shared miRNAs by these two
mRNAs is calculated in the following.












In the formula, N is the number of all miRNAs in the
dataset, M and K represent the total numbers of miRNAs
regulating mR1 and mR2 respectively, and x is the number
of common miRNAs shared by mR1 and mR2. The mRNA-
mRNA pairs with significant sharing of miRNAs (p-value
<0.01) and significant positive correlations (p-value <0.01)
are regarded as candidate miRNA sponge interactions. We
further remove the candidate miRNA sponge interactions
that are actually TF-target interactions or PPIs and the can-
didate miRNA sponges which are not involved in any
miRNA sponge interactions are removed too. Finally, all
the reserved miRNA sponges and miRNAs in a bicluster
are regarded as a miRNA sponge module.
Results and Discussion
miRNA sponge modules for BRCA
The default values of the tuning parameters a and b are
set to 0.5, and the threshold s of regulatory scores is set
to −0.3 for the reconstruction of miRNA-target interac-
tions. As shown in Table 1, we identify four miRNA
sponge modules. As illustrated in Fig. 2, there are many
common miRNA sponge interactions (385,172) between
Module 2 and Module 3, and almost all miRNA sponge
interactions (37,948) in Module 4 exist in Module 1. How-
ever, there is no overlap of miRNA sponge interactions
among the four modules. This result implies that most
miRNA sponge interactions tend to be module-
conserved across two modules, and a small portion of
miRNA sponge interactions are module-specific (i.e.
only exist in a single module). The detail information of
the four modules and module-specific miRNA sponge
interactions can be seen in Additional file 1.
miRNA sponge modules are biologically meaningful
As described previously (see the Data sources section),
we collect a list of 428 BRCA miRNAs and 2949 BRCA
genes. We also collect a list of 40 unique GO terms
associated with 10 cancer hallmarks (Self Sufficiency in
Growth Signals, Insensitivity to Antigrowth Signals,
Evading Apoptosis, Limitless Replicative Potential, Sus-
tained Angiogenesis, Tissue Invasion and Metastasis,
Genome Instability and Mutation, Tumor Promoting
Inflammation, Reprogramming Energy Metabolism, and
Evading Immune Detection). Only five cancer hallmarks
(Self Sufficiency in Growth Signals, Insensitivity to Anti-
growth Signals, Evading Apoptosis, Tissue Invasion and
Metastasis, and Genome Instability and Mutation) have
related gene sets in more than half of the associated GO
terms (details in Additional file 2). As a result, we have a
list of 2224 unique genes associated with the five repre-
sentative cancer hallmarks. The list of BRCA miRNAs,
BRCA genes, and cancer hallmark genes can be seen in
Additional file 3.
As shown in Fig. 3, the percentages of BRCA miRNAs,
BRCA genes, and cancer hallmark genes are different
due to the different components of each miRNA sponge
module. Overall, 10.81% of miRNAs are BRCA miRNAs,
Table 1 miRNA sponge modules in BRCA
miRSM #miRNAs #miRNA sponges #miRNA sponge interactions
Module 1 110 546 69468
Module 2 130 1213 470817
Module 3 92 1142 422427
Module 4 105 354 37952
(See figure on previous page.)
Fig. 1 The pipeline of miRSM. We construct miRNA-mRNA correlation matrix using Pearson method, and miRNA-mRNA context++ score matrix
using putative miRNA-target binding information. Next, miRNA-mRNA regulatory score matrix is inferred by combining miRNA-mRNA correlation
and context++ score matrix. A biclustering method is then used to generate miRNA-mRNA biclusters. We identify miRNA sponge interactions in
each miRNA-mRNA bicluster, and remove the candidate miRNA sponges which are not involved in any miRNA sponge interactions. The remaining
candidate miRNA sponges and miRNAs in each bicluster are considered as a miRNA sponge module
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21.81% of miRNA sponges are BRCA genes, and 13.40%
of miRNA sponges are cancer hallmark genes in the
identified miRNA sponge modules.
Since differentially expressed genes with abnormal
expression are closely associated with the occurrence
and development of cancer, we also perform differential
expression analysis on the BRCA expression profiles using
limma package [38] of Bioconductor. As a result, 278
miRNAs (adjusted p-value <0.01, adjusted by Benjamini &
Hochberg method), and 5602 mRNAs (adjusted p-value
<1E-04) are identified to be differentially expressed at sig-
nificant level (details in Additional file 4). We find that the
miRNA sponges in the four miRNA sponge modules are
all differentially expressed mRNAs, and the percentages of
Fig. 2 Overlaps and differences of miRNA sponge interactions in the four miRNA sponge modules
Fig. 3 The percentage of BRCA miRNAs, BRCA miRNA sponges, and cancer hallmark miRNA sponges in the four miRNA sponge modules
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differentially expressed miRNAs of Module 1 to Module 4
are 54.55% (60 out of 110), 41.54% (54 out of 130), 61.96%
(57 out of 92) and 60.95% (64 out of 105), respectively.
This result indicates that the identified modules are func-
tional miRNA sponge modules, and may be closely associ-
ated with the occurrence and development of BRCA.
To uncover the biological machanism in BRCA, we fur-
ther conduct functional annotation analysis of the miRNA
sponges using GeneCodis [39] (the online tool at http://
genecodis.cnb.csic.es/). The top 5 enriched GO (Gene
Ontology) [40] terms and KEGG (Kyoto Encyclopedia of
Genes and Genomes) [41] pathways are listed in Table 2.
As shown in Table 2, most enriched GO biological
processes and KEGG pathways are shared by Module 2
and Module 3, and there also exist common pathways
between Module 1 and Module 4. This suggests that
similar modules (Module 2 and Module 3, Module 1
and Module 4) with many overlaps of miRNA sponge in-
teractions tend to have similar biological functions, and
vice versa. Moreover, all modules have many enriched
GO biological processes and KEGG pathways related to
BRCA, such as Signal transduction (GO:0007165) [42],
Cell cycle (GO:0007049, KEGG:04110) [43], and Pathways
in cancer (KEGG:05200). Since the BRCA dataset is a can-
cer dataset, the result demonstrates that the discovered
miRNA sponge modules are closely associated with the
biological condition of the dataset. The module-specific
miRNA sponge interactions among four modules are also
significantly enriched in Signal transduction (GO:0007165)
and Pathways in cancer (KEGG:05200). The result indi-
cates that these module-specific miRNA sponge interac-
tions may be involved in the progression and development
of BRCA.
In summary, miRNA sponge modules are biologically
significant, which may imply that the miRNA sponge
modules discovered based on the BRCA dataset can indeed
reveal the biological mechanism in BRCA. The detailed in-
formation of significant GO terms and KEGG pathways for
the miRNA sponges in each module and module-specific
interactions can be found in Additional file 5.
Validation of the interactions in the miRNA sponge
modules
In this section, we validate two types of interactions (miRNA
sponge interactions and miRNA-target interactions) in the
identified miRNA sponge modules. For the ground truth of
validation, we have collected 46 experimentally validated
mRNA-related miRNA sponge interactions, and 5195
experimentally validated miRNA-target interactions with
strong evidence (details in Additional file 6). For the valid-
ation of miRNA sponge interactions, Module 2 has five
experimentally validated miRNA sponge interactions from a
small number (46) of ground truth interactions. They are all
PTEN-related miRNA sponge interactions (five genes
including KLF6, LRCH1, MBNL1, SERINC1 and ZEB2
compete with PTEN). In the case of the validation of
miRNA-target interactions, the numbers of experimentally
validated miRNA-target interactions with strong evidence in
Module 1 and Module 3 achieve 17 and 71, respectively.
The detailed information can be seen in Additional file 7.
Comparison with other existing methods in identifying
miRNA sponge interactions
In this section, we compare the performance of miRSM
with other existing methods in terms of the numbers of
breast cancer-related miRNA sponge interactions and
experimentally validated miRNA sponge interactions in
the findings by the methods. We define that breast
cancer-related miRNA sponge interactions are those in
which the two interactive parties exist in the list of 2949
breast cancer genes (i.e. the breast cancer genes col-
lected in the Data sources section). Since the mathemat-
ical modelling approaches in the third category are only
applied to study a small number of miRNA sponge
interactions, we don’t compare miRSM with them in this
study. Therefore, in this study, we select three typical
methods from the first two categories (pair-wise correl-
ation approach and partial association approach) for the
comparison study. The first method is the Positive
Correlation (PC) method [8, 9], which is based on the
positive correlation between each pair of interacting
miRNA sponges. The second method is the Sensitivity
Partial Pearson Correlation (SPPC) method [12], which
uses partial correlations to estimate the contributed
effect of common miRNAs on miRNA sponge interact-
ing pairs. The third method is Hermes [13], which uses
conditional mutual information to estimate partial asso-
ciations between miRNA sponges.
To make a fair comparison, we use the same p-value
cutoff (0.01) to calculate significance of the findings of
shared miRNAs and the positive correlations of possible
miRNA sponge interaction pairs. For the SPPC method,
the cutoff of sensitivity correlation (the difference be-
tween Pearson Correlation and Partial Pearson Correl-
ation) is set to 0.3, which is the value used in [12].
We compare the results of miRSM with three different
parameter settings with those of the other 3 methods.
As shown in Table 3, the numbers of validated miRNA
sponge interactions for the three different parameter set-
tings of miRSM are all 5, indicating a stable validation
results of our method. In the case of the number of vali-
dated miRNA sponge interactions, our method performs
better than SPPC and Hermes, but slightly worse than
PC. However, our method generally performs better than
the other three methods in the percentage of breast
cancer-related miRNA sponge interactions.
Since PTEN-related miRNA sponge interactions are
widely studied, we further focus on studying the overlap
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Table 2 Top 5 enriched GO terms and KEGG pathways for the miRNA sponges in each module and module-specific interactions
miRSM Items #miRNA sponges Adjusted p-value
Module 1 GO:0000278-Mitotic cell cycle 45 7.36E-28
GO:0051301-Cell division 43 4.10E-27
GO:0007049-Cell cycle 41 4.61E-18
GO:0007067-Mitosis 28 2.50E-17
GO:0000236-Mitotic prometaphas 20 3.59E-16
KEGG:04110-Cell cycle 17 7.73E-10
KEGG:04914-Progesterone-mediated oocyte maturation 9 0.000432
KEGG:05110-Vibrio cholerae infection 7 0.000676
KEGG:03060-Protein export 5 0.000728
KEGG:04114-Oocyte meiosis 9 0.001271
Module 2 GO:0007165-Signal transduction 124 2.37E-26
GO:0007275-Multicellular organismal development 106 1.41E-24
GO:0045944-Positive regulation of transcription from RNA polymerase II promoter 73 2.16E-19
GO:0000122-Negative regulation of transcription from RNA polymerase II promoter 55 3.39E-15
GO:0007155-Cell adhesion 62 9.26E-14
KEGG:04060-Cytokine-cytokine receptor interaction 35 5.45E-10
KEGG:04080-Neuroactive ligand-receptor interaction 33 1.40E-08
KEGG:05200-Pathways in cancer 36 2.53E-08
KEGG:04510-Focal adhesion 26 1.40E-07
KEGG:04144-Endocytosis 25 3.30E-07
Module 3 GO:0007165-Signal transduction 113 1.01E-22
GO:0045944-Positive regulation of transcription from RNA polymerase II promoter 73 6.85E-21
GO:0007275-Multicellular organismal development 94 5.77E-20
GO:0000122-Negative regulation of transcription from RNA polymerase II promoter 52 1.98E-14
GO:0007155-Cell adhesion 58 9.76E-13
KEGG:04060-Cytokine-cytokine receptor interaction 31 4.46E-08
KEGG:04080-Neuroactive ligand-receptor interaction 31 5.24E-08
KEGG:05200-Pathways in cancer 34 6.92E-08
KEGG:04920-Adipocytokine signaling pathway 15 9.78E-08
KEGG:04010-MAPK signaling pathway 29 2.07E-07
Module 4 GO:0000278-Mitotic cell cycle 42 2.03E-32
GO:0051301-Cell division 40 2.79E-31
GO:0000236-Mitotic prometaphase 20 6.71E-20
GO:0007067-Mitosis 26 7.54E-20
GO:0006260-DNA replication 24 8.54E-20
KEGG:04110-Cell cycle 14 2.48E-09
KEGG:03060-Protein export 5 0.00015
KEGG:05110-Vibrio cholerae infection 6 0.000517
KEGG:04914-Progesterone-mediated oocyte maturation 6 0.003029
KEGG:04141-Protein processing in endoplasmic reticulum 8 0.003089
Module-specific GO:0007275-Multicellular organismal development 146 6.67E-30
GO:0007165-Signal transduction 165 2.46E-29
GO:0045944-Positive regulation of transcription from RNA polymerase II promoter 95 5.49E-21
GO:0000122-Negative regulation of transcription from RNA polymerase II promoter 72 7.02E-17
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and differences between PTEN-related miRNA sponge
interactions identified by miRSM_default, PC, SPPC,
and Hermes. Figure 4 illustrates that different compu-
tational methods identify different sets of PTEN-
related miRNA sponge interactions. Specifically, many
PTEN-related miRNA sponge interactions are only
inferred by miRSM.
Conclusions
miRNA sponge effect is a novel type of gene regulation at
the post-transcriptional level. The crosstalks between
miRNA sponges involve many classes of RNAs, mainly
including protein-coding and non-coding RNAs. Among
different types of miRNA sponges (protein-coding RNAs,
lncRNAs, pseudogenes, circRNAs, etc), the vast majority
of them are protein-coding RNAs. Thus, we focus on
mRNA-related miRNA sponge modules in this study.
Identifying miRNA sponge interaction network using in
silico methods is an emerging research field. The funda-
mental principle of the identification of miRNA sponge
interactions using in silico methods are based on experi-
mental evidence for miRNA sponges. The basic experi-
mental evidence for miRNA sponges is that the
overexpression of the putative miRNA sponges leads to
increased expression of the competing RNAs, and vice
versa. That is to say, miRNA sponge interaction pairs are
positively correlated at expression level. Until now, an ubi-
quitous limitation of in silico methods assessing miRNA
sponge interactions is that they are wholly dependent
upon unweighted miRNA-target interactions at sequence
level, and rarely take expression level into account. In fact,
integrating both sequence level and expression level infor-
mation lead to the discovery of more candidate miRNA
sponge interaction pairs when exploring miRNA sponge
interaction networks. In addition, an underlying problem
of existing in silico methods is that they also regard other
known gene regulatory interactions or molecular interac-
tions (e.g. TF-target interactions and PPIs) as miRNA
sponge interactions. Actually, these interactions are direct
interactions rather than crosstalks between miRNA sponges.
miRNA sponge interaction networks provide a global
way to study the biological functions of miRNA sponges
in cancer. Since modularity is an important feature of
cancer progression and development, it is extremly ne-
cessary to investigate functional miRNA sponge modules
associated with cancer from a local point of view. There-
fore, in this paper, we propose miRSM to identify
miRNA sponge modules. The method integrates data
source from both sequence level and expression level,
and uses regulatory scores to reconstruct miRNA-target
interactions and infer miRNA-mRNA biclusters in which
a subset of mRNAs compete with each other to bind
with a subset of miRNAs. Moreover, we remove miRNA
sponge interactions that are experimentally validated
TF-target interactions or PPIs to improve the prediction
of miRNA sponge modules.
miRSM is a parametric method, i.e. the identified
miRSM modules and the validation results are closely
Table 2 Top 5 enriched GO terms and KEGG pathways for the miRNA sponges in each module and module-specific interactions
(Continued)
GO:0007264-Small GTPase mediated signal transduction 58 6.02E-15
KEGG:05200-Pathways in cancer 56 2.26E-13
KEGG:04510-Focal adhesion 39 2.92E-11
KEGG:04144-Endocytosis 34 1.77E-08
KEGG:04060-Cytokine-cytokine receptor interaction 39 7.93E-08
KEGG:04810-Regulation of actin cytoskeleton 34 9.26E-08
The p-values are adjusted by Benjamini-Hochberg (BH) method
Table 3 Comparison with other existing three methods in the number of breast cancer-related miRNA sponge interactions and
experimentally validated miRNA sponge interactions
Methods #Interactions #Breast cancer-related
interactions (percentage)
Validated miRNA sponge interactions #Validated
interactions
miRSM_default 577544 21669 (3.75%) SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
miRSM_v1 169617 6104 (3.60%) SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
miRSM_v2 1228533 46186 (3.76%) SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
PC 933516 28354 (3.04%) HIAT1:PTEN, SERINC1:PTEN, KLF6:PTEN, TNKS2: PTEN, PDGFRA:RB1,
LRCH1:PTEN, AFF1:PTEN
7
SPPC 177371 6434 (3.63%) LRCH1:PTEN, KLF6:PTEN 2
Hermes 43144 1018 (2.36%) JARID2:PTEN, RUNX1:PTEN, AFF1:PTEN 3
“:” denotes “competing with”. Three miRSM networks including miRSM_default with a = b = 0.5 and s = -0.3, miRSM_v1 with a = 0.45, b = 0.55 and s = -0.3, and
miRSM_v2 with a = 0.55, b = 0.45 and s = -0.3 are used to compare
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related with the tuning parameters a and b, and the
threshold s of regulatory scores. As shown in Table 4,
the threshold s is a negative value, and is associated
with the number of candidate miRNA sponges. The
smaller the value of s is, the less the number of miRNA
sponge interactions is. The parameters a and b denote
the contributions of expression data and sequence data
to the identification of miRNA-target interactions, and
the default values of a and b are the same. If a > b, the
number of miRNA sponge interactions will increase,
and vice versa.
The comparison results show that miRSM per-
forms better than or comparable to the other three
existing methods (PC, SPPC, Hermes). Different
methods have their own merits, leading to different
sets of miRNA sponge interactions. The results
focusing on PTEN-related miRNA sponge interac-
tions show that miRSM can identify many different
miRNA sponge interactions from the other three
methods.
In summary, miRSM can be a promising method
for identifying miRNA sponge modules, and hence
provides new insights into the regulatory me-
chanisms and functions of miRNA sponges in dif-
ferent biological processes, including pathogenesis of
cancers.
Fig. 4 Overlaps and differences between PTEN-related miRNA sponge interactions identified by miRSM, PC, SPPC, and Hermes
Table 4 The number of identified miRNA sponge interactions and experimentally validated miRNA sponge interactions under
different parameter settings
Parameter settings of miRSM #Interactions Validated miRNA sponge interactions #Validated interactions
a = 0.5, b = 0.5, s = -0.3 577544 SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
a = 0.5, b = 0.5, s = -0.25 2033124 AFF1:PTEN, ZEB2:PTEN, SERINC1:PTEN, MBNL1:PTEN, LRCH1:PTEN,
KLF6:PTEN, FN1: VCAN
7
a = 0.5, b = 0.5, s = -0.35 61161 / 0
a = 0.5, b = 0.5, s = -0.4 1041 / 0
a = 0.5, b = 0.5, s = -0.45 84 / 0
a = 0.4, b = 0.6, s = -0.3 17972 LRCH1:PTEN, KLF6:PTEN 2
a = 0.45, b = 0.55, s = -0.3 169617 SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
a = 0.55, b = 0.45, s = -0.3 1228533 SERINC1:PTEN, LRCH1:PTEN, KLF6:PTEN, ZEB2:PTEN, MBNL1:PTEN 5
a = 0.6, b = 0.4, s = -0.3 2029912 AFF1:PTEN, ZEB2:PTEN, SERINC1:PTEN, MBNL1:PTEN, LRCH1:PTEN,
KLF6:PTEN, FN1:VCAN
7
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Additional files
Additional file 1: miRNA sponge modules and module-specific miRNA
sponge interactions. Four modules are identified by miRSM with the
default parameter setting. The module-specific miRNA sponge
interactions only exist in a single miRNA sponge module. (XLSX 15 mb)
Additional file 2: GO terms and related genes associated with 10
hallmarks of cancer. There are 40 unique GO terms associated with 10
hallmarks of cancer. Only 5 cancer hallmarks (Self Sufficiency in Growth
Signals, Insensitivity to Antigrowth Signals, Evading Apoptosis, Tissue
Invasion and Metastasis, and Genome Instability and Mutation) have
related gene sets in more than half associated GO terms. (XLSX 72 kb)
Additional file 3: The list of BRCA miRNAs, BRCA genes, and cancer
hallmark genes. There are 428 BRCA miRNAs, 2949 BRCA genes and 2224
cancer hallmark genes. (XLSX 77 kb)
Additional file 4: Differentially expressed miRNAs and mRNAs in BRCA
dataset. The p-values are adjusted by Benjamini-Hochberg (BH) method.
We identify 278 miRNAs (adjusted p-value <0.01), and 5602 mRNAs
(adjusted p-value <1E-04) to be differentially expressed at significant
level. (XLSX 1 mb)
Additional file 5: The significant GO terms and KEGG pathways for miRNA
sponges in each module and module-specific interactions. The p-values are
adjusted by Benjamini-Hochberg (BH) method, and the p-value cutoff is set to
0.05. (XLSX 209 kb)
Additional file 6: Experimentally validated mRNA-related miRNA sponge
interactions and miRNA-target interactions with strong evidence. After
removing replicate interactions, we have collected 46 experimentally
validated mRNA-related miRNA sponge interactions, and 5195
experimentally validated miRNA-target interactions with strong evidence
for validation. (XLSX 152 kb)
Additional file 7: Experimentally validated miRNA sponge interactions and
miRNA-target interactions in the modules identified by miRSM. (XLSX 11 kb)
Abbreviations
BH: Benjamini-hochberg; BRCA: Breast invasive carcinoma; ceRNA: Competing
endogenous RNA; circRNA: Circular RNA; GO: Gene ontology; HPRD: Human protein
reference database; KEGG: Kyoto encyclopedia of genes and genomes; KNN: k-nearest
neighbours; lncRNA: Long non-coding RNA; miRNA: microRNA; miRSM: miRNA
sponge module; PC: Positive correlation; PPI: Protein-protein interaction;
SPPC: Sensitivity partial pearson correlation; TCGA: The cancer genome altas
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